Cargando…
Rab22a is a novel prognostic marker for cell progression in breast cancer
Breast cancer (BC) is the most common female malignant tumor worldwide. The mechanism of tumorigenesis is still unclear. Ras-related proteins in brain (Rab)22a belongs to the Ras superfamily, which may act as an oncogene and participate in carcinogenesis. The present study aims to identify whether R...
Autores principales: | He, Miao, Shen, Leihua, Jiang, Chengwei, Gao, Ge, Wang, Keren, Jiao, Yan, Sun, Liang, Cui, Yingnan, Ke, Zirui, Yang, Zhaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053859/ https://www.ncbi.nlm.nih.gov/pubmed/32124943 http://dx.doi.org/10.3892/ijmm.2020.4486 |
Ejemplares similares
-
Rab22a is a novel prognostic marker for cell progression in breast cancer
por: He, Miao, et al.
Publicado: (2021) -
Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer
por: Zheng, Dandan, et al.
Publicado: (2020) -
Risk factors of breast intraductal lesions in patients without pathological nipple discharge
por: Shen, Leihua, et al.
Publicado: (2020) -
Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients
por: Meng, Xiangyu, et al.
Publicado: (2022) -
Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma
por: Wen, Fukai, et al.
Publicado: (2023)